Archive: Company News
Heraeus Medical to Host Interactive Webinar “Orthopedic Surgery in COVID-19 Times”
Orthopedic surgery in COVID-19 times
To educate surgical teams in the management of periprosthetic joint infections in pandemic times, the PALACADEMY® of Heraeus Medical has expanded it virtual program. Teams are now invited to take part in the first interactive webinar
“Periprosthetic joint infections in pandemic times. Focus on risk patients and prevention.”
Company News: Mikrogen erhält CE-Zertifizierung für Antikörpertest zum Nachweis von SARS-CoV-2 / COVID-19
– German only –
— Test kompatibel mit üblichen Laborautomaten (ELISA-Systemen)
— Herstellung von 1.600.000 Testkits pro Monat möglich
— Lösung erlaubt erstmals zuverlässige, kostengünstige und flächendeckende Testung
Mikrogen GmbH, ein Unternehmen, das gentechnisch hergestellte in vitro Diagnostika entwickelt, hat heute die CE-Kennzeichnung seines recomWell SARS-CoV-2 IgG-Tests bekannt gegeben.
Company News: TolerogenixX Reports Positive Phase Ib Data of its Lead Product to Combat Transplant Rejection
– Product shows excellent safety and tolerability
– Enables long-term reduction of standard medications and side effects while maintaining immune tolerance and transplant function
– Findings endorsed by third-party experts
TolerogenixX GmbH, a biopharmaceutical company developing personalized, cellular therapies to combat organ rejection and autoimmune diseases, today announced the publication of positive Phase Ib results of its lead product MIC-Lx in The Journal of Clinical Investigation (https://doi.org/10.1172/JCI133595). Read more…
Company News: BellaSeno Appoints Dr. Mohit Chhaya as Chief Executive Officer
– Former CEO Dr. Simon Champ to become a member of BellaSeno´s Supervisory Board
BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that co-founder and former Chief Technology Officer Dr. Mohit Chhaya, PhD, has been appointed as the Company´s Chief Executive Officer. Starting on April 1, 2020, he will take over duties from BellaSeno´s current CEO and co-founder Dr. Simon Champ, MBA. Simon Champ will become a member of BellaSeno’s Supervisory Board.